BackGenerate Biomedicines Overview
Generate Biomedicines, Inc.

Generate Biomedicines Target Price

Analysts' average 12-month price target for Generate Biomedicines is $30.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.57

Average Target Price

$30.00138.7% upside

1 analysts in the last 4 months

High: $30 | Low: $30

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-28H.C. Wainwright$30138.7% upsideOpen
2026-05-14Morgan StanleySean Laaman$2275% upsideOpen
2026-05-08H.C. WainwrightMitchell Kapoor$2598.9% upsideOpen

Generate Biomedicines (GENB) FAQ

Generate Biomedicines (GENB) currently reports a target price of $30. Use the charts on this page to explore Generate Biomedicines's target price history and peer comparisons.

Analysts' average 12-month price target for Generate Biomedicines is $30, about 138.7% upside from the current share price of $12.57. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $30, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Generate Biomedicines, and consider following GENB for alerts when major investors trade the stock.